Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

96 results
Display

A biomarker, osteoprotegerin, in patients undergoing hemodialysis

Ko GJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coronary artery calcification and serum markers

Kim SB

  • KMID: 2256405
  • Korean J Med.
  • 2007 May;72(5):443-445.
Coronary artery calcification is associated with the increased cardiovascular mortality and the extent of atheromatous plaque, especially in the hemodialysis patients. Vascular calcification was in the past considered a passive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of nicotine on the formation of osteocalcin and osteoprotegerin and synthesis of its mRNA in MG63 osteoblast-like cell

Yang JH, Park SB

  • KMID: 2400561
  • Korean J Orthod.
  • 2004 Dec;34(6):514-525.
The purpose of this study was to evaluate the correlation between nicotine and the activity of bone forming cell. MG63 osteoblast-like cells were used for this study. Several factors were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Osteoprotegerin Gene A163G, G1181C Polymorphisms with Bone Mass in Postmenopausal Korean Women

Kwon DJ, You YO, Kim DH, Jo HH, Kim JH, Lim YT, Kim EJ, Kim JH

  • KMID: 2272130
  • Korean J Obstet Gynecol.
  • 2003 Aug;46(8):1560-1566.
OBJECTIVE: To examine the relationship between Osteoprotegerin gene polymorphisms, and bone mineral density (BMD). METHODS: Restriction fragment length polymorphisms at the Osteoprotegerin A163G (promoter), G1181C (exon 1) gene site, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Luteolin Induces the Differentiation of Osteoblasts

Ko SY

  • KMID: 1457182
  • Int J Oral Biol.
  • 2010 Sep;35(3):99-106.
Luteolin is a flavonoid that exists in a glycosylated form in celery and green pepper. Flavonoids possess antioxidant and anti-inflammatory properties and can reduce the expression of key inflammatory molecules...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Osteoprotegerin Gene Polymorphisms with bone Mass in Postmenopausal Korean Women

Lee SW, Kwon DJ, You YO, Kim DH, Lee HJ, Kim JH, Kim EJ, Kim JH

  • KMID: 2272334
  • Korean J Obstet Gynecol.
  • 2004 May;47(5):886-893.
OBJECTIVE: To examine the relationship between Osteoprotegerin gene polymorphisms, and bone mineral density (BMD). METHODS: Restriction fragment length polymorphisms at the Osteoprotegerin A163G, T950C, G1181C gene site, and BMD at...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effect of five osteotropic factors on osteoprotegerin mRNA expression in gingival fibroblasts

Ko YK

PURPOSE: Osteoprotegerin (OPG) is a secreted glycoprotein and a member of the tumor necrosis factor (TNF) receptor family that inhibits bone resorption by suppressing osteoclastogenesis. Gingival fibroblasts (GF) play a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Association of Osteoprotegerin with Cardiovascular Disease and the New York Heart Association Classification

Sung KC, Kwon CH, Rhee EJ, Kim BJ, Kim BS, Kang JH

BACKGROUND AND OBJECTIVES: Recent studies have suggested that there is a significant correlation between elevated serum Osteoprotegerin (OPG) levels and cardiovascular diseases. We investigated whether the serum OPG levels were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of serum osteoprotegerin with coronary artery calcification scores in patients with asymptomatic type 2 diabetes

Cho EH, Lee DG, Kim SW

  • KMID: 2259118
  • Korean J Med.
  • 2010 Aug;79(2):163-170.
BACKGROUND/AIMS: Osteoprotegerin (OPG), a member of the tumor necrosis factor (TNF) receptor superfamily, is involved in bone metabolism and vascular calcification. However, the relationship between serum OPG levels and coronary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intraarticular Corticosteroids Modulate the Osteoprotegerin/Receptor Activator of Nuclear Factor-kappaB Ligand System in the Synovial Fluid in Patients with Rheumatoid Arthritis

Lee JS, Suh JT

PURPOSE: Despite the fact that intraarticular corticosteroids are a longstanding adjuvant treatment for inflammatory arthritis, their mechanisms of action are not completely understood. This study evaluated the osteoprotegerin (OPG) and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Elevated Serum Osteoprotegerin Levels in Systemic Lupus Erythematosus

Shin YJ, Hong KH, Yoo SA, Choi JJ, Kim WU, Cho CS

  • KMID: 2202225
  • J Korean Rheum Assoc.
  • 2006 Sep;13(3):185-192.
OBJECTIVE: To determine the serum levels of soluble osteoprotegerin (OPG), decoy receptor of receptor activator of nuclear factor kB ligand (RANKL), in patients with systemic lupus erythematosus (SLE) and to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Involvement of the Ca2+ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation

Fu Y, Gu J, Wang Y, Yuan Y, Liu X, Bian J, Liu ZP

The purpose of this study was to determine whether the Ca2+ signaling pathway is involved in the ability of osteoprotegerin (OPG) to inhibit osteoclast differentiation and maturation. RAW264.7 cells were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Transglutaminase-2 Is Involved in Expression of Osteoprotegerin in MG-63 Osteosarcoma Cells

Lee HJ, Lee CH

  • KMID: 1502488
  • Biomol Ther.
  • 2013 May;21(3):204-209.
Osteoprotegerin (OPG) is a secreted glycoprotein and a member of the tumor necrosis factor receptor superfamily. It usually functions in bone remodeling, by inhibiting osteoclastogenesis through interaction with a receptor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Plasma Osteoprotegerin with Adiponectin and Difference according to Obesity in Men with Metabolic Syndrome

Na W, Sohn C

Osteoprotegerin (OPG) plays a core role in bone reformation by antagonizing the effect of receptor activator of nuclear factor kappa-B ligand (RANKL), and mediates vascular calcification in cardiovascular disease patients....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health

Tabari ZA, Azadmehr A, Tabrizi MA, Hamissi J, Ghaedi FB

PURPOSE: The receptor activator of nuclear factor kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system plays a significant role in osteoclastogenesis, activation of osteoclasts, and regulation of bone resorption. This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of mRANKL in rat PDL cell

Kim HS, Chung HJ, Kim YJ, Kim OS

As the periodontal ligament cells show similar phenotype with osteoblasts, periodontal ligament cells are thought to play an important role in alveolar bone remodeling. According to recent studies, receptor activation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of Osteoprotegerin and Osteoclast Differentiation Factor in Human Periodontal Ligament Fibroblast Cells

Rew SH, Heo SR, Kim HS, Oh KO

Recently, soluble TNF receptor homolog osteoprotegerin (OPG) and its membrane-bound ligand osteoclast differentiation factor (ODF) were found to regulate osteoclast formation and function, and bone metabolism. It is now well...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Relationship between Polymorphisms of Wnt Antagonists Genes and Production of Osteoprotegerin (OPG)-soluble receptor Activator of NF-kappaB Ligand (sRANKL) by Whole Blood Cells

Kim H, Lee DO, Ku SY, Kim SH, Choi YM, Kim JG

  • KMID: 2329527
  • J Reprod Endocrinol.
  • 2012 Apr;4(1):20-29.
OBJECTIVES: To investigate the association between polymorphisms of Wnt antagonists genes and the production of osteoprotegerin (OPG), and soluble receptor activator of nuclear factor-kappaB ligand (sRANKL) by whole blood cells...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum osteoprotegerin and fetuin-A level is associated with coronary artery calcification score in the patients with end-stage renal disease

Kim SW, Jung HH, Han H

  • KMID: 2256407
  • Korean J Med.
  • 2007 May;72(5):451-458.
BACKGROUND: Coronary artery calcification is frequently seen in hemodialysis patients. The development and progression of coronary artery calcification is similar to osteogenesis, and a naturally occurring serum inhibitor of calcification...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of Receptor Activator of NF-kappaB Ligand and Osteoprotegerin in Cholesteatoma

Byun JY, Cha CI, Yeo SG, Kim SW, Cho JS

  • KMID: 2276455
  • Korean J Otolaryngol-Head Neck Surg.
  • 2005 Aug;48(8):955-960.
BACKGROUND AND OBJECTIVES: Bone resorption in middle ear cholesteatoma is mostly responsible for serious complications of the disease, but the pathogenesis of destruction due to bone resorption has not been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr